Nonalcoholic Fatty Liver / Nonalcoholic steatohepatitis (NASH)

    Not Recruiting
  • sponsor
Updated on 7 February 2023


Nonalcoholic Fatty Liver / Nonalcoholic steatohepatitis (NASH)


Nonalcoholic steatohepatitis (NASH) is an advanced form of fatty liver disease. It is caused by excess fat in the liver that leads to inflammation and tissue injury.
People with type 2 diabetes, obesity, high cholesterol, insulin resistance, and high blood pressure may have NASH.
ACRC Trials is conducting a research study to evaluate an investigational drug for NASH.
  • Study participation is up to 6 years
  • Eligible participants receive study-related medical evaluations and the investigational drug at no charge
  • Reimbursement for travel and meal expenses may be provided
  • Details
    Condition Liver Disease, Liver Disorders, Hepatitis
    Clinical Study IdentifierTX150235
    Last Modified on7 February 2023

    Similar trials to consider


    Browse trials for

    Not finding what you're looking for?

    Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

    Sign up as volunteer

    user name

    Added by • 



    Reply by • Private

    Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

      The passcode will expire in None.

    No annotations made yet

    Add a private note
    • abc Select a piece of text from the left.
    • Add notes visible only to you.
    • Send it to people through a passcode protected link.
    Add a private note